查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
多普勒超聲系統市場——增長、趨勢和預測 (2023-2028)
市場調查報告書
商品編碼
1273308

多普勒超聲系統市場——增長、趨勢和預測 (2023-2028)

Doppler Ultrasound Systems Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在預測期內，多普勒超聲系統市場的複合年增長率為 7.5%。

大流行的爆發影響了多普勒超聲市場。 與 COVID-19 感染相關的高血栓事件發生率，例如深靜脈血栓形成 (DVT) 和急性肺栓塞，促進了大流行期間多普勒超聲的使用。 例如，2021 年 7 月 NCBI 的一篇文章指出，在大流行期間無症狀 DVT 的發生率增加 (60.87%)。 此外，雖然彩色多普勒超聲能夠檢測無症狀患者的 DVT，但靜脈多普勒超聲現在被認為是對有血栓並發症風險的 COVID-19 患者的重要干預措施，允許醫生做出決定。據說它對 因此，市場在大流行期間呈現正增長，預計在預測期內將繼續保持上升趨勢。

隨著人口老齡化，慢性病的流行、新興市場醫療保健支出的增加、醫療保健工作者數量的增加以及用於診斷的醫療保健支出的增加正在推動市場。 先進的多普勒超聲診斷技術的發展也是推動市場增長的關鍵因素。 癌症、心血管疾病、胃腸道疾病和腎臟疾病等慢性病在全球範圍內普遍存在。 例如，2022年，美國癌症協會（ACS）估計，2023年美國將有106180例結腸癌新病例和44850例直腸癌新病例。 此外，美國癌症協會 2021 年的一份報告發現，男性患結直腸癌的終生風險約為 23 分之一 (4.3%)，女性約為 25 分之一 (4.0%)。 多普勒超聲是癌症診斷的基本要求之一，此類病例數量的穩步增加將推動對多普勒超聲機的需求。

此外，已經進行了大量研究來闡明多普勒超聲在各種疾病中的診斷應用。 例如，2021 年 7 月，中國大連醫科大學的一個研究團隊開始了一項研究，調查多普勒超聲在早期慢性腎髒病患者中的診斷用途。 此外，2022 年 4 月，加拿大溫哥華不列顛哥倫比亞大學的另一個研究小組發現，多普勒成像經常用於評估腎移植以及評估腎血管流量和通暢性。我們正在宣布調查結果，它正在被使用。

市場進入者還關注多普勒超聲系統，推動市場擴張。 例如，2021 年 1 月，EagleView ultrasound 推出了一款無線便攜式超聲設備，以實惠的價格提供準確的超聲成像。 同樣，由紅杉印度和 EDBI 支持的新加坡醫療技術公司 Us2.ai 的全自動心臟超聲工具 Us2.v1 已於 2021 年 9 月獲得 FDA 批准，該工具可測量 2D 和多普勒。 多普勒超聲系統的進步預計將在預測期內推動市場擴張。

但是，多普勒超聲系統的嚴格監管政策和過高的成本預計會阻礙預測期內的市場增長。

多普勒超聲系統市場趨勢

預計手持設備市場在預測期內實現顯著增長

手持設備是用於監測孕婦血流量的設備，還有許多其他用途。 手持設備易於使用，可以跟上要求苛刻和快節奏的醫療保健環境。 市場上的大多數手持設備都可以輕鬆掃描、順暢地更改部門以及無縫地用於各種檢查。 足病醫生通常使用手持式多普勒成像作為一種無創血管評估方法。 由於對這些設備的高需求，主要參與者正在推出新的產品線，這可能對該細分市場的增長產生積極影響。 例如，2021 年 3 月，通用電氣旗下的 GE Healthcare 發布了一款新型無線手持超聲設備 Vscan Air。 一種名為 Vscan Air 的袖珍型彩色多普勒超聲通過以客戶為導向的創新為世界各地的患者提供更加個性化的護理。

此外，2022 年 2 月，皇家飛利浦通過為便攜式超聲“Lumify 脈搏波多普勒”添加改進的血液動力學評估和測量功能，擴展了其超聲產品陣容。 諸如此類的改進有望促進該領域的市場擴張。 此外，外周動脈疾病和靜脈血栓栓塞症發病率的上升有望很快支持該領域的擴展。 受深靜脈血栓形成 (DVT) 或肺栓塞 (PE) 影響的確切人數尚不清楚，但根據 2022 年 4 月更新的 CDC 數據，美國每年有 90 萬人受到 DVT 和 PE 的影響。

此外，根據世界衛生組織 2021 年 3 月的數據，到 2021 年底，將有 780 萬名女性在過去五年中被診斷出患有乳腺癌，使其成為世界上最常見的癌症。我了解. 根據同一數據，2021 年全球將有約 230 萬女性被診斷出患有乳腺癌。 隨著慢性病患病率的上升，對用於實際診斷目的的便攜式和手持式多普勒超聲系統的需求正在增加。

多普勒超聲系統市場-IMG1

預計在預測期內北美將實現大幅增長

北美佔多普勒超聲系統市場的主要份額。 由於成像技術在疾病診斷和治療中的應用越來越多，北美多普勒超聲系統市場正在整體擴大。 例如，2022 年 3 月，加拿大初創公司 Flosonics Medical 宣布了一款可穿戴無線多普勒超聲系統。 因此，該行業的市場擴張預計將由創新驅動。 此外，該地區越來越多的醫院、診所、門診手術中心 (ACS) 以及對醫療保健項目的投資也為市場擴張做出了貢獻。 例如，加拿大和魁北克政府共同投資了 209 個基礎設施項目，以對魁北克的醫院和其他護理中心等健康和社會服務機構進行現代化改造、重建和升級。 此信息是在加拿大政府於 2021 年 7 月發布的新聞稿中提供的。 聯邦基礎設施、社區、衛生和社會服務部長宣布，對這 209 個基礎設施項目的投資將達到 1.883 億美元。 這些投資應該能讓醫院獲得最先進的醫療設備，如多普勒超聲系統。 此外，作為取消基於走廊的醫療保健戰略的一部分，加拿大安大略省於 2021 年 3 月宣布將支付高達 5300 萬美元來設計和建造新的格雷布魯斯醫療服務馬克代爾醫院。

主要產品發布、市場參與者和製造商的集中存在、主要參與者之間的收購和合作夥伴關係、美國醫院數量的增加等是推動該國多普勒超聲系統市場增長的一些因素. 是。 例如，根據美國醫院協會 (AHA) 2022 年發布的數據，2021 年全國有超過 6093 家醫院在運營。 同樣，在 2022 年 9 月，飛利浦獲得了 FDA 510(k) 許可，用於優化便攜性和性能的超聲緊湊型系統。

多普勒超聲系統市場-IMG2

多普勒超聲系統行業概覽

由於市場上存在一些主要參與者，多普勒超聲系統市場適度整合。 每家公司都專注於其設備的技術進步，以佔領較大的市場份額。 市場參與者包括 Koninklijke Philips N.V.、通用電氣公司（GE Healthcare）、Siemens Healthcare GmbH、Fujifilm Corporation、Samsung、Shenzhen Mindray Bio-Medical Electronics、Canon Inc.、Trivitron Healthcare Private Limited、BK Medical Holding Company, Inc、CIMON Medical AS、NOVASIGNAL CORPORATION、ESAOTE SPA、Clarius 等。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 調查假設和市場定義
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 由於老齡化社會的到來，慢性病增加
    • 超聲診斷技術的進步
    • 發達國家的醫療支出增加
  • 市場製約因素
    • 多普勒超聲系統成本高
    • 嚴格的監管程序
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（市場規模：百萬美元）

  • 按設備類型
    • 手推車底座
    • 手持設備
  • 通過使用
    • 放射科
    • 婦產科
    • 心髒病
    • 其他用途
  • 最終用戶
    • 醫院
    • 診斷中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Koninklijke Philips N.V.
    • General Electric Company（GE Healthcare）
    • Siemens Healthcare GmbH
    • FUJIFILM Corporation（FUJIFILM VisualSonics, Inc.）
    • Samsung
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Canon Inc.
    • Trivitron Healthcare Private Limited
    • BK Medical Holding Company, Inc.
    • CIMON Medical AS
    • NOVASIGNAL CORPORATION
    • ESAOTE SPA
    • Clarius

第7章 市場機會與將來動向

簡介目錄
Product Code: 67879

The doppler ultrasound systems market is expected to register a CAGR of 7.5% over the forecast period.

The outbreak of the pandemic impacted the doppler ultrasound market. A high rate of thrombotic events was associated with the COVID-19 infection, such as deep vein thrombosis (DVT) and acute pulmonary embolism, which propelled the use of doppler ultrasound during the pandemic. For instance, as per a July 2021 NCBI article, during the pandemic, an increased incidence of asymptomatic DVT (60.87%) was noted. It also mentioned that color doppler ultrasound allowed detection of DVT in asymptomatic patients, but venous doppler ultrasound was accepted as a critical intervention for COVID-19 patients at risk of thrombotic complications, which helped physicians to make decisions. Thus, the market witnessed positive growth during the pandemic and is expected to continue the upward trend over the forecast period.

The rising prevalence of chronic diseases coupled with the aging population, growing healthcare spending in developed nations, an increase in healthcare providers, and healthcare spending on diagnosis are the major drivers for the market. The development of advanced doppler ultrasound diagnostic technologies is another important element fueling market growth. Chronic diseases like cancer, and cardiovascular, gastrointestinal, and kidney ailments are becoming more prevalent throughout the world. For instance, in 2022, the American Cancer Society (ACS) that there would be an estimated 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer in the United States in 2023. Furthermore, according to a 2021 report by the American Cancer Society, the lifetime risk of developing colorectal cancer was about 1 in 23 (4.3%) for men and 1 in 25 (4.0%) for women. Doppler ultrasound is one of the essential requirements for the diagnosis of cancer and this steady increase in the number of cases will propel the demand for doppler ultrasound systems.

In addition, numerous studies are being conducted to determine the diagnostic use of the doppler ultrasound in various disorders. For instance, a team of researchers from Dalian Medical University in China began a study in July 2021 to investigate the diagnostic use of doppler ultrasound in patients with early chronic renal disease. Furthermore, in April 2022, a different team of researchers from the University of British Columbia in Vancouver, Canada, published a research study that states that doppler imaging is frequently used to evaluate transplanted kidneys and is utilized to evaluate renal vascular flow and patency.

The market participants are also concentrating on doppler ultrasound systems and driving market expansion. For instance, in January 2021, EagleView ultrasound launched its wireless portable ultrasound device, which provides accurate ultrasound imaging and is affordable as well. Similarly, Us2.ai, a Singapore-based medtech company supported by Sequoia India and EDBI, gained FDA approval for Us2.v1, a fully automated cardiac ultrasound tool to measure 2D and doppler, in September 2021. It is projected that during the course of the projection period, advances in the doppler ultrasound system will spur market expansion.

However, stringent regulatory policies and the excessive cost of doppler ultrasound systems are expected to hamper the market growth over the forecast period.

Doppler Ultrasound Systems Market Trends

The Handheld Devices Segment is Expected to Witness Considerable Growth Over the Forecast Period

Handheld devices are devices used to monitor blood flow in pregnant women and also have numerous other applications. Handheld gadgets are easy to use and can keep up with the demanding and fast-paced healthcare setting. The majority of commercially available handheld devices offer simple scanning, smooth departmental changes, and seamless use for a variety of tests. Podiatrists routinely use handheld doppler examinations as a non-invasive vascular assessment method. Owing to the high demand for these devices, the key players are launching new product lines, which may positively impact segment growth. For instance, In March 2021, GE Healthcare, a part of General Electric, introduced the Vscan Air, a new wireless handheld ultrasound instrument. A pocket-sized ultrasound with a color doppler called the Vscan Air uses customer-driven innovation to offer more individualized care for patients all around the world.

Furthermore, in February 2022, Royal Philips added improved hemodynamic assessment and measuring capabilities to its portable Lumify Pulse Wave Doppler ultrasound, expanding its ultrasound line. Improvements like these will fuel market expansion in the sector. Additionally, it is anticipated that the segment expansion will soon be supported by the rising incidence of peripheral artery disease and venous thromboembolism. Although the exact number of people affected by deep vein thrombosis (DVT) or pulmonary embolism (PE) is unknown, DVT and PE impact 900,000 people annually in the United States, according to data from the CDC updated in April 2022.

Moreover, according to March 2021 WHO data, there were 7.8 million women alive at the end of 2021 who had received a diagnosis of breast cancer in the previous five years, making it the most common cancer in the world. The same source also stated that there were approximately 2.3 million women worldwide who were diagnosed with breast cancer in 2021. The demand for portable and handheld doppler ultrasonography equipment for practical diagnosis purposes is rising as the prevalence of chronic diseases rises.

Doppler Ultrasound Systems Market - IMG1

North America is Expected to Witness Considerable Growth Over the Forecast Period

North America holds a major share of the doppler ultrasound systems market. The market for doppler ultrasound systems in North America is expanding overall due to the rise in the application of imaging technologies for illness diagnosis and treatment. For instance, in March 2022, the wearable, wireless doppler ultrasound system was introduced by Canadian startup Flosonics Medical. Therefore, market expansion in the area is anticipated to be fueled by innovations. Additionally, a rise in the number of hospitals, clinics, and ambulatory surgery centers (ACSs) and investments in healthcare projects across the region is contributing to the market growth. For instance, the governments of Canada and Quebec worked together to invest in 209 infrastructure projects to modernize, redevelop, and upgrade health and social services institutions in Quebec, including hospitals and other care centers. This information was provided in a press release issued by the Canadian government in July 2021. The investment for these 209 infrastructure projects would total USD 188.3 million, according to announcements from the federal ministers of infrastructure, communities, and health and social services. Due to these investments, hospitals must have access to cutting-edge medical equipment like doppler ultrasound systems. Additionally, as part of its strategy to eliminate hallway health care, the Canadian province of Ontario announced in March 2021 that it would pay up to USD 53.0 million to finance the design and construction of the new Grey Bruce Health Services Markdale Hospital.

Key product launches, high concentration of market players or manufacturers' presence, acquisition and partnerships among major players, and an increasing number of hospitals in the United States are some of the factors driving the growth of the doppler ultrasound systems market in the country. For instance, according to American Hospital Association (AHA) data published in 2022, there were more than 6,093 operating hospitals in the country in 2021. Similarly, in September 2022, Philips received FDA 510(k) clearance for an ultrasound compact system to optimize portability and performance.

Doppler Ultrasound Systems Market - IMG2

Doppler Ultrasound Systems Industry Overview

The doppler ultrasound systems market is moderately consolidated due to the presence of a few key players in the market. The companies are focused on the technological advancement of the devices to gain significant market shares. Some of the market players are Koninklijke Philips N.V., General Electric Company (GE Healthcare), Siemens Healthcare GmbH, Fujifilm Corporation, Samsung, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Canon Inc., Trivitron Healthcare Private Limited, BK Medical Holding Company, Inc., CIMON Medical AS, NOVASIGNAL CORPORATION, ESAOTE SPA, and Clarius, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases Coupled with Increasing Aging Population
    • 4.2.2 Advances in Ultrasound Diagnostic Technologies
    • 4.2.3 Increasing Healthcare Expenditure in Developed Countries
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Doppler Ultrasound Systems
    • 4.3.2 Stringent Regulatory Procedures
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Device Type
    • 5.1.1 Trolly-Based
    • 5.1.2 Handheld
  • 5.2 By Application
    • 5.2.1 Radiology
    • 5.2.2 Obstetrics and Gynecology
    • 5.2.3 Cardiology
    • 5.2.4 Other Applications
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End-Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Koninklijke Philips N.V.
    • 6.1.2 General Electric Company (GE Healthcare)
    • 6.1.3 Siemens Healthcare GmbH
    • 6.1.4 FUJIFILM Corporation (FUJIFILM VisualSonics, Inc.)
    • 6.1.5 Samsung
    • 6.1.6 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 6.1.7 Canon Inc.
    • 6.1.8 Trivitron Healthcare Private Limited
    • 6.1.9 BK Medical Holding Company, Inc.
    • 6.1.10 CIMON Medical AS
    • 6.1.11 NOVASIGNAL CORPORATION
    • 6.1.12 ESAOTE SPA
    • 6.1.13 Clarius

7 MARKET OPPORTUNITIES AND FUTURE TRENDS